miR-9: From function to therapeutic potential in cancer

被引:35
作者
Khafaei, Mostafa [1 ]
Rezaie, Ehsan [2 ]
Mohammadi, Ali [1 ]
Gerdehsang, Payam Shahnazi [3 ]
Ghavidel, Sara [4 ]
Kadkhoda, Sepideh [5 ]
Zahra, Atieh Zorrieh [5 ]
Forouzanfar, Narjes [6 ]
Arabameri, Hossein [1 ]
Tavallaie, Mahmood [1 ]
机构
[1] Baqiyatallah Med Sci Univ, Human Genet Res Ctr, POB 19395-5487, Tehran, Iran
[2] Baqiyatallah Univ Med Sci, Mol Biol Res Ctr, Syst Biol & Poisonings Inst, POB 19395-5487, Tehran, Iran
[3] Islamic Azad Univ, Damghan Branch, Dept Biol, Damghan, Iran
[4] Islamic Azad Univ, Tonekabon Branch, Dept Cell & Mol Biol, Tehran, Iran
[5] Univ Social Welf & Rehabil Sci, Genet Res Ctr, Tehran, Iran
[6] Mashhad Univ Med Sci, Med Genet Res Ctr, Mashhad, Razavi Khorasan, Iran
关键词
cancer therapy; microRNA; miR-9; suppressor; tumor oncogene; MICRORNA EXPRESSION PROFILES; REGULATES E-CADHERIN; FACTOR-KAPPA-B; TUMOR-SUPPRESSOR; BLADDER-CANCER; CELL-PROLIFERATION; UVEAL MELANOMA; PROGNOSTIC VALUE; DNA METHYLATION; PROSTATE-CANCER;
D O I
10.1002/jcp.28210
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Malignant neoplasms are regarded as the main cause of death around the world; hence, many research studies were conducted to further perceive molecular mechanisms, treatment, and cancer prognosis. Cancer is known as a major factor for health-related problems in the world. The main challenges associated with these diseases are prompt diagnosis, disease remission classification and treatment status forecast. Therefore, progressing in such areas by developing new and optimized methods with the help of minimally invasive biological markers such as circular microRNAs (miRNAs) can be considered important. miRNA interactions with target genes have specified their role in development, apoptosis, differentiation, and proliferation and also, confirm direct miRNA function in cancer. Different miRNAs expression levels in various types of malignant neoplasms have been observed to be associated with prognosis of various carcinomas. miR-9 seems to implement opposite practices in different tissues or under various cancer incidences by influencing different genes. Aberrant miR-9 levels have been observed in many cancer types. Therefore, we intended to investigate the precise role of miR-9 in patients with malignant neoplasms. To this end, in this study, we attempted to examine different studies to clarify the overall role of miR-9 as a prognostic marker in several human tumors. The presented data in this study can help us to find the novel therapeutic avenues for treatment of human cancers.
引用
收藏
页码:14651 / 14665
页数:15
相关论文
共 118 条
  • [31] miRNAs in human cancer
    Farazi, Thalia A.
    Spitzer, Jessica I.
    Morozov, Pavel
    Tuschl, Thomas
    [J]. JOURNAL OF PATHOLOGY, 2011, 223 (02) : 102 - 115
  • [32] Overexpression of miR-9 in mast cells is associated with invasive behavior and spontaneous metastasis
    Fenger, Joelle M.
    Bear, Misty D.
    Volinia, Stefano
    Lin, Tzu-Yin
    Harrington, Bonnie K.
    London, Cheryl A.
    Kisseberth, William C.
    [J]. BMC CANCER, 2014, 14
  • [33] Frenzel Anna, 2010, Genes Cancer, V1, P660, DOI 10.1177/1947601910377488
  • [34] Evidence for the biogenesis of more than 1,000 novel human microRNAs
    Friedlaender, Marc R.
    Lizano, Esther
    Houben, Anna J. S.
    Bezdan, Daniela
    Banez-Coronel, Monica
    Kudla, Grzegorz
    Mateu-Huertas, Elisabet
    Kagerbauer, Birgit
    Gonzalez, Justo
    Chen, Kevin C.
    LeProust, Emily M.
    Marti, Eulalia
    Estivill, Xavier
    [J]. GENOME BIOLOGY, 2014, 15 (04):
  • [35] Prognostic role of microRNA-21 in various carcinomas: a systematic review andmeta-analysis
    Fu, Xiaonan
    Han, Yijie
    Wu, Ying
    Zhu, Xiaoli
    Lu, Xin
    Mao, Feng
    Wang, Xuejing
    He, Xuelian
    Zhao, Yuhang
    Zhao, Yulan
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2011, 41 (11) : 1245 - 1253
  • [36] Functional Implications of Human-Specific Changes in Great Ape microRNAs
    Gallego, Alicia
    Mele, Marta
    Balcells, Ingrid
    Garcia-Ramallo, Eva
    Torruella-Loran, Ignasi
    Fernandez-Bellon, Hugo
    Abello, Teresa
    Kondova, Ivanela
    Bontrop, Ronald
    Hvilsom, Christina
    Navarro, Arcadi
    Marques-Bonet, Tomas
    Espinosa-Parrilla, Yolanda
    [J]. PLOS ONE, 2016, 11 (04):
  • [37] Gansler T, 2010, CA-CANCER J CLIN, V60, P1, DOI [10.3322/caac.20049, 10.3322/caac.20073]
  • [38] Genome-Wide miRNA Expression Profiling Identifies miR-9-3 and miR-193a as Targets for DNA Methylation in Non-Small Cell Lung Cancers
    Heller, Gerwin
    Weinzierl, Marlene
    Noll, Christian
    Babinsky, Valerie
    Ziegler, Barbara
    Altenberger, Corinna
    Minichsdorfer, Christoph
    Lang, Gyoergy
    Doeme, Balazs
    End-Pfuetzenreuter, Adelheid
    Arns, Britt-Madeleine
    Grin, Yuliya
    Klepetko, Walter
    Zielinski, Christoph C.
    Zoechbauer-Mueller, Sabine
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (06) : 1619 - 1629
  • [39] Expression and functional significance of VE-cadherin in aggressive human melanoma cells: Role in vasculogenic mimicry
    Hendrix, MJC
    Seftor, EA
    Meltzer, PS
    Gardner, LMG
    Hess, AR
    Kirschmann, DA
    Schatteman, GC
    Seftor, REB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (14) : 8018 - 8023
  • [40] Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer
    Huang, Yen-Lin
    Hung, Jung-Tung
    Cheung, Sarah K. C.
    Lee, Hsin-Yu
    Chu, Kuo-Ching
    Li, Shiou-Ting
    Lin, Yu-Chen
    Ren, Chien-Tai
    Cheng, Ting-Jen R.
    Hsu, Tsui-Ling
    Yu, Alice L.
    Wu, Chung-Yi
    Wong, Chi-Huey
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (07) : 2517 - 2522